Isabel M Álvarez

4PUBLICATIONS

45CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|May 26, 2026

Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial.

|Dec 12, 2025

Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer.

Miguel Martín, Ángel L Guerrero-Zotano, María E Pérez-López

|Jul 24, 2021

Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer.

José Manuel López-Vega, Isabel Álvarez, Antonio Antón

|Feb 14, 2020

Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer.

I Alvarez-Lopez, S Bezares, E Dalmau Portulas

Pageof 1

Frequent Collaborators

Rosalía Caballero

Federico Rojo

José J Ponce-Lorenzo

Miguel Martín

Angel L Guerrero-Zotano

2 joint publications

Raquel Andrés

2 joint publications

Manuel Ruiz-Borrego

2 joint publications

Ana Santaballa Bertran

2 joint publications

Emilio Alba

2 joint publications

Noelia Martinez Jañez

Frequent Collaborators

Rosalía Caballero

Federico Rojo

José J Ponce-Lorenzo

Miguel Martín